Perceptive Advisors LLC Verona Pharma PLC Put Options Transaction History
Perceptive Advisors LLC
- $3.83 Billion
- Q3 2024
Put Options
1 transactions
Others Institutions Holding VRNA
# of Institutions
169Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Nea Management Company, LLC Timonium, MD5.58MShares$303 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$272 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$229 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$193 Million14.95% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$184 Million5.24% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.31B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...